PainReform (PRFX) News Today → RSVP: Charles Payne’s Cash Flow Workshop (From Unstoppable Prosperity) (Ad) Free PRFX Stock Alerts $0.63 -0.03 (-4.55%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31, 2024 | globenewswire.comPainReform Announces Receipt of Nasdaq Minimum Bid Price NotificationMay 16, 2024 | finanznachrichten.dePainReform Ltd: PainReform Provides Business Update for the First Quarter of 2024May 15, 2024 | msn.comPRFX Stock Earnings: PainReform Misses EPS for Q1 2024May 15, 2024 | globenewswire.comPainReform Provides Business Update for the First Quarter of 2024May 8, 2024 | globenewswire.comPainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.comApril 18, 2024 | globenewswire.comPainReform Announces Closing of $4 Million Public OfferingApril 16, 2024 | finance.yahoo.comPainReform Announces Pricing of $4 Million Public OfferingApril 9, 2024 | msn.comEXCLUSIVE: PainReform's Non-Opiate Post-Surgical Pain Relief Treatment Outperforms Rival Medicine Under Various Testing ConditionsApril 9, 2024 | finance.yahoo.comPainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing ConditionsApril 9, 2024 | globenewswire.comPainReform's Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing ConditionsApril 4, 2024 | finance.yahoo.comUK watchdog says Theramex-Viatris deal raises competition concernsApril 4, 2024 | markets.businessinsider.comBuy Rating Affirmed for PainReform as PRF-110 Shows Promise in Non-Opioid Pain Management MarketApril 2, 2024 | finance.yahoo.comEXCLUSIVE: PainReform Reaches 50% Enrollment Target For Phase 3 Study For Its Lead Postoperative Pain DrugApril 2, 2024 | globenewswire.comPainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in BunionectomyMarch 7, 2024 | markets.businessinsider.comBuy Rating for PainReform’s PRF-110: Promising Non-Opioid Pain Solution Amidst Opioid CrisisMarch 1, 2024 | globenewswire.comPainReform Provides Year-End Business UpdateJanuary 22, 2024 | finance.yahoo.comPainReform to Present at the Microcap Conference in Atlantic CityJanuary 12, 2024 | msn.comPainReform files to sell 968,545 ordinary shares for holdersJanuary 5, 2024 | markets.businessinsider.comBuy Rating for PainReform’s PRF-110: Superior Spreadability Signaling Market AdvantageJanuary 3, 2024 | finance.yahoo.comPainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain ReliefDecember 26, 2023 | finance.yahoo.comPainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross ProceedsDecember 19, 2023 | benzinga.comPainReform Stock (NASDAQ:PRFX) Dividends: History, Yield and DatesNovember 19, 2023 | finanznachrichten.dePainReform Ltd: PainReform Provides Business Update for the Third Quarter of 2023November 18, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: PainReform (PRFX) and Tenet Healthcare (THC)November 15, 2023 | finance.yahoo.comPainReform Provides Business Update for the Third Quarter of 2023November 12, 2023 | morningstar.comPainReform Ltd Ordinary Shares PRFXSeptember 12, 2023 | markets.businessinsider.comPainReform (PRFX) Gets a Buy from Maxim GroupSeptember 11, 2023 | finance.yahoo.comPainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master FileSeptember 7, 2023 | finance.yahoo.comPainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, HungarySeptember 7, 2023 | finance.yahoo.comPainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, HungarySeptember 5, 2023 | finance.yahoo.comPainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York CityAugust 30, 2023 | finance.yahoo.comPRFX - PainReform Ltd.August 11, 2023 | finance.yahoo.comPainReform Provides Business Update for the Second Quarter of 2023July 19, 2023 | finanznachrichten.dePainReform Ltd: PainReform Regains Compliance with Nasdaq Continued Listing RequirementsJuly 19, 2023 | finance.yahoo.comPainReform Regains Compliance with Nasdaq Continued Listing RequirementsJuly 14, 2023 | markets.businessinsider.comPRFX Stock: The $2.7 Million Reason PainReform Is Up 100% TodayJuly 14, 2023 | finance.yahoo.comPainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private PlacementJuly 14, 2023 | marketbeat.comTrading was temporarily halted for "PRFX" at 02:07 PM with a stated reason of "LULD pause."July 14, 2023 | marketbeat.comTrading was temporarily halted for "PRFX" at 10:07 AM with a stated reason of "LULD pause."July 14, 2023 | marketbeat.comTrading was temporarily halted for "PRFX" at 10:07 AM with a stated reason of "LULD pause."July 14, 2023 | marketbeat.comTrading was temporarily halted for "PRFX" at 10:07 AM with a stated reason of "LULD pause."July 14, 2023 | marketbeat.comTrading was temporarily halted for "PRFX" at 10:07 AM with a stated reason of "LULD pause."July 14, 2023 | marketbeat.comTrading was temporarily halted for "PRFX" at 09:07 AM with a stated reason of "LULD pause."July 14, 2023 | marketbeat.comTrading was temporarily halted for "PRFX" at 09:07 AM with a stated reason of "LULD pause."July 14, 2023 | marketbeat.comTrading was temporarily halted for "PRFX" at 09:07 AM with a stated reason of "LULD pause."July 14, 2023 | marketbeat.comTrading was temporarily halted for "PRFX" at 09:07 AM with a stated reason of "LULD pause."July 12, 2023 | marketwatch.comPainReform Shares Unwind From Tuesday Surge After PricingJuly 12, 2023 | msn.comPainReform (NASDAQ:PRFX) Tanks on $2.7M Registered Direct OfferingJuly 12, 2023 | finance.yahoo.comPainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private PlacementJuly 11, 2023 | benzinga.comWhat's Going On With PainReform (PRFX) Stock? Get PainReform News Delivered to You Automatically Sign up to receive the latest news and ratings for PRFX and its competitors with MarketBeat's FREE daily newsletter. Email Address RSVP: Charles Payne’s Cash Flow Workshop (Ad)Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? It's true. Click here to register for free. PRFX Media Mentions By Week PRFX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRFX News Sentiment▼0.000.76▲Average Medical News Sentiment PRFX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRFX Articles This Week▼01▲PRFX Articles Average Week Get PainReform News Delivered to You Automatically Sign up to receive the latest news and ratings for PRFX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SEEL News Today LIXT News Today HOTH News Today PTIX News Today CLVR News Today SNPX News Today BFRI News Today KA News Today BPTH News Today DRUG News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRFX) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored